Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
---|
04/24/2002 | CN1083444C Process for preparing N-alkyl ammonium acetonitrile compounds |
04/24/2002 | CN1083419C Pentanoic acid derivatives, its preparation, medicinal materials having same and use thereof |
04/23/2002 | US6376665 Antiarthritic agents, antiinflammatory agents |
04/23/2002 | US6376514 Piperidine-derived compounds containing a quinolyl group that inhibits p-glycoprotein transport protein activity; for treating cancer and other diseases |
04/23/2002 | US6376506 Sulfamide-metalloprotease inhibitors |
04/23/2002 | US6376495 Antidiabetic piperazine derivatives, processes for their preparation and compositions containing them |
04/23/2002 | US6376494 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents |
04/18/2002 | WO2002031025A2 Biodegradable poly(beta-amino esters) and uses thereof |
04/18/2002 | WO2002030929A1 Novel pleuromutilin derivatives |
04/18/2002 | WO2002030915A2 Aryl-indane compounds for use as inhibitors of p-glycoprotein mediated transport |
04/18/2002 | WO2002030881A1 Sulfonylguanidine |
04/18/2002 | WO2002030880A2 N-substituted amino acid derivatives (factor xa inhibitors) |
04/18/2002 | WO2002030870A2 Substituted c-cyclohexylmethylamine derivatives |
04/18/2002 | WO2002012166A3 Triamine derivative melanocortin receptor ligands and methods of using same |
04/18/2002 | WO2002006207A3 Novel coupling components for oxidation colouring agents |
04/18/2002 | WO2001087830A3 Substituted thioacetamides |
04/18/2002 | US20020045777 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones, hyperproliferative disorders, and treatment and/or prophylaxis of impaired glucose tolerance and diabetes. |
04/18/2002 | US20020045753 E.g., (S)-N-(4-(4-((3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2 -yl)-carbonyl)-1-piperazinyl)phenyl)-2-thiophenecarboximidamide , or a salt thereof. |
04/18/2002 | US20020045751 Thyromimetic organic compounds |
04/18/2002 | US20020045749 Antibacterial agents |
04/18/2002 | US20020045629 Sleep, eating and brain disorders, wakefulness promoters; Parkinson's disease, antiischemic agents, stroke, chronic fatigue syndrome; antidepressants; schizophrenia, nervous system disorders; multiple sclerosis, cognition activators |
04/18/2002 | US20020045626 Benzylpiperazinyl and piperidinyl ethanone derivatives: dopamine receptor subtype specific ligands |
04/18/2002 | DE10048716A1 Use of sulfonylguanidine derivatives, mostly new compounds, for treating e.g. pain and neurodegeneration, have affinity for the gabapentin binding site |
04/18/2002 | CA2424107A1 Sulfonylguanidines |
04/18/2002 | CA2423935A1 Substituted c-cyclohexylmethylamine derivatives |
04/17/2002 | EP1196406A1 Amino ceramide-like compounds and therapeutic methods of use |
04/17/2002 | EP1196404A1 Piperazine derivatives as modulators of chemokine receptor activity |
04/17/2002 | EP1196403A1 Antipsychotic cyclic n-aralkyl amines |
04/17/2002 | EP1196389A1 N-heterocyclic derivatives with neuronal activity |
04/17/2002 | EP1196371A1 Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity |
04/17/2002 | CN1345317A (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for production thereof and pharmaceutical compositions containing the same |
04/17/2002 | CN1345309A Diaryl derivatives and their use as medicaments |
04/17/2002 | CN1345308A Acetylenic alpha-amino acid based sulfonamide hydroxamic acid TACE inhibitors |
04/17/2002 | CN1345307A N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists |
04/17/2002 | CN1345305A Method of preparing granular N-alkyl-ammonium acetonitrile salts |
04/17/2002 | CN1345303A Oxamic acids and derivatives as thyroid receptor ligands |
04/17/2002 | CN1345302A Production of acrylic monomers |
04/17/2002 | CN1344717A Quaternary ammonium salt compound of piperazine with pain relieving effect |
04/17/2002 | CN1082959C Substituted benzothienylpiperazines, their use as medicaments and processes for their preparation |
04/17/2002 | CN1082953C Process to prepare oxazolidinones |
04/17/2002 | CN1082790C Herbicides |
04/16/2002 | US6372778 Sulfonamide inhibitors of aspartyl protease |
04/16/2002 | US6372762 Heterocyclic compounds for nervous system disorders |
04/16/2002 | US6372758 Sulfamato hydroxamic acid metalloprotease inhibitor |
04/16/2002 | US6372752 Enzyme inhibitors, respiratory system disorders, tuberculosis and mycobacterium bactericides |
04/16/2002 | US6372734 Crystalline dibenzothiazepine derivative and its use as an antipsychotic agent |
04/16/2002 | CA2009690C Phenylhydrazones, the manufacture thereof and therapeutic and cosmetic compositions prepared therefrom |
04/11/2002 | WO2002028829A2 Peptide deformylase inhibitors |
04/11/2002 | WO2002028816A1 Substituted 5-amino-1-pentene-3-ol derivatives |
04/11/2002 | WO2002028815A1 Pharmaceutical compounds |
04/11/2002 | WO2002028810A2 Retinoids for the treatment of emphysema |
04/11/2002 | WO2001066247A3 A nickel-rhenium catalyst for use in reductive amination processes |
04/11/2002 | WO2001044161A3 Method for producing combinatorial libraries of aryl-substituted amines |
04/11/2002 | WO2001036374A3 Bis-basic compounds for use as tryptase inhibitors, method for producing the same and their use as medicaments |
04/11/2002 | US20020042524 Process for cis-1{2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy] ethyl}pyrrolidine |
04/11/2002 | US20020042517 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
04/11/2002 | US20020042511 New derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
04/11/2002 | US20020042443 Estrogen agonist / antagonist metabolites |
04/11/2002 | US20020042414 Antiallergens |
04/11/2002 | US20020042410 Central nervous system disorders therapy |
04/11/2002 | US20020042406 Ring opening metathesis of alkenes |
04/11/2002 | US20020042399 Analgesics; skin disorders |
04/11/2002 | US20020042376 Antiinflammatory agents; autoimmune disease; antiischemic agents |
04/11/2002 | US20020042357 Polypharmacophoric agents |
04/11/2002 | DE10141565A1 Cyclobutanone compounds useful in liquid crystal media, especially for plasma-addressed displays, comprises substituted trans-cyclohexylene, p-phenylene and-or other cyclic groups, |
04/11/2002 | DE10048714A1 5-Amino-1-penlen-3-ol-Derivate 5-amino-1-penlen-3-ol derivatives |
04/11/2002 | DE10046993A1 Substituierte Zimtsäureguanidide, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltendes Medikament Substituted Zimtsäureguanidide, processes for their preparation, their use as a medicament and they drug-containing |
04/11/2002 | CA2419777A1 Pharmaceutical compounds |
04/10/2002 | EP1195376A1 Azoamidine compounds and their use as polymerization initiators |
04/10/2002 | EP1194422A1 Biaryl compounds |
04/10/2002 | EP1194415A2 Novel piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same, and a process for their preparation |
04/10/2002 | EP1194405A1 Sulfur-containing thyroxane derivatives and their use as hair growth promotors |
04/10/2002 | EP1194403A1 Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same |
04/10/2002 | EP0739351B1 Monomeric diols and phosphate linked oligomers formed therefrom |
04/10/2002 | CN1344266A Novel compounds |
04/10/2002 | CN1344259A Processes and intermediates for prepn. of 1,3-diazin-b 6-ones and uracils |
04/10/2002 | CN1344250A 间苯二酚衍生物 Resorcinol derivatives |
04/10/2002 | CN1344247A Multicyclic compounds which inhibit beukocyte adhesion mediated by VLA-4 |
04/09/2002 | US6369265 Heterocoupling reaction, mixing in a liquid an aryl halide, bonding to aromatic rings, grignard reaction, metal compound and heterocyclic carbene |
04/09/2002 | US6369226 Substituted benzamide inhibitors of rhinovirus 3C protease |
04/09/2002 | US6369194 Alpha-beta-diketo compounds produced by reacting an alpha-keto acid or acid chloride with a ylide such as (cyanomethylene)phosphoranes, oxidizing the cyano diketo phoshorane and reacting with a nucleophile |
04/09/2002 | US6369073 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
04/09/2002 | CA2120229C Methylpiperazinoazepine derivatives, their preparation and their use |
04/09/2002 | CA2090321C Therapeutically useful 2-aminotetralin derivatives |
04/04/2002 | WO2002026720A2 PIPERAZINE BASED INHIBITORS OF FACTOR Xa |
04/04/2002 | WO2002026683A1 Tandem acyl-claisen rearrangement in the preparation of chiral products |
04/04/2002 | WO2002010178A8 Adamantyl groups containing phosphane ligands, the production and use thereof in catalytical reactions |
04/04/2002 | WO2002004407A3 7-substituted tetracycline compounds |
04/04/2002 | WO2001090717A3 Linker arms for nanocrystals and compounds thereof |
04/04/2002 | WO2001090716A3 Linker arms for nanocrystals and compounds thereof |
04/04/2002 | WO2001085694A3 Substituted diamide derivatives useful as motilin antagonists |
04/04/2002 | WO2001047898A3 Substituted piperazine derivatives and their use as inhibitors of the microsomal triglyceride transfer protein (mtp) |
04/04/2002 | US20020040162 Contrast media for angiography |
04/04/2002 | US20020040061 Compounds such as 1-(3-(2-hydroxybenzoylamino)propyl)-2-pyrrolidinone; dosage forms of bioactive agents or drugs |
04/04/2002 | US20020040060 2'-methyl-biphenyl-2-carboxylic acid-(3,5-bis-trifluoromethyl-benzyl)-methyl-amide, for example; treating disease related to neurokinin 1 receptor |
04/04/2002 | US20020040025 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
04/04/2002 | US20020040024 A phenoxy substituted piperidine derivative, useful for treating or preventing histamine H3 receptor activity |
04/04/2002 | US20020039998 Administering to human therapeutically effective amount of a combination of drug which is metabolized by cytochrome p450 monooxygenase or pharmaceutically acceptable salt thereof and ritonavir |
04/04/2002 | DE10044792A1 Substituierte Phenylcyclohexancarbonsäureamide und ihre Verwendung Substituted Phenylcyclohexancarbonsäureamide and their use |
04/03/2002 | EP1192945A2 Use of an estrogen agonist/antagonist for treating osteoarthritis |